Sale

Latin America Aortic Stent Graft Market

Latin America Aortic Stent Graft Market Size, Share, Trends: By Product: Abdominal Aortic Stent Grafts, Thoracic Aortic Stent Grafts; By End User: Hospitals, Ambulatory Surgical Centers, Others; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Demand Indicators, Others; Supplier Landscape; 2024-2032

Latin America Aortic Stent Graft Market Size

The global aortic stent graft market  was valued at USD 3.1 billion in 2023, with Latin America holding a significant market share. The market is driven by the growing demand for minimally invasive surgical techniques to treat vascular diseases. It is expected to grow at a CAGR of 5.8% during the forecast period of 2024-2032, with the values likely to attain USD 5.2 billion by 2032.

 

Latin America Aortic Stent Graft Market Outlook

  • In January 2024, W. L. Gore & Associates, Inc., announced that the FDA has approved its lower profile GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis.  The innovative stent graft offers more choices and flexibility to healthcare providers when treating patients with complicated blood vessel issues and is anticipated to elevate the Latin America aortic stent graft market value.
  • Abdominal aortic aneurysm (AAA) is the most common form of aortic aneurysm, with older adults at a higher risk of developing the condition. The growing aging population in the Latin American region is likely to augment the market demand for effective treatment solutions  including aortic stent grafts.
  • The market share is influenced by the growing number of clinical trials and post-market surveillance studies to evaluate the effectiveness and safety profile of new aortic stent grafts.

 

Latin America Aortic Stent Graft Market Analysis

Aortic stent grafts are tube-like devices consisting of fabric-covered metal mesh. It is used in the treatment of aortic aneurysms and helps reinforce the wall of the aorta and prevent the aneurysm from rupturing. To repair an abdominal aortic aneurysm, a minimally invasive procedure called endovascular aneurysm repair (EVAR) is performed in which an aortic stent graft is required. There is a growing preference for minimally invasive surgeries as they are associated with shorter recovery times and lower risk of complications as compared to conventional open surgeries. This rising patient inclination towards endovascular aneurysm repair is expected to drive the Latin America aortic stent graft market growth in the coming years.

 

Abdominal aortic aneurysm (AAA) is the most common form of aortic aneurysm and poses a significant health challenge in Latin America. Older adults tend to be more susceptible to developing the condition, with the disease reported to be highly prevalent in patients over 60 years of age.  As a minimally invasive treatment option, aortic stent grafts are suitable for elderly patients who may experience higher risks in open surgical techniques due to age-related health issues. Thus, the growing aging population in the region is likely to augment the market demand for effective treatment solutions including aortic stent grafts in healthcare settings.

 

One of the major Latin America aortic stent graft market trends is the rising technological advancements that are leading to the development of more effective and minimally invasive stent grafts. In January 2024, W. L. Gore & Associates, Inc.,  a global materials science company, announced that its lower profile GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) was approved by the United States Food and Drug Administration (FDA) for treating complex vascular disease. The innovative stent graft has 6 French (Fr) compatible configurations among balloon expandable stent-grafts, offering more choices and flexibility to healthcare providers when treating patients with complicated blood vessel issues. The introduction of such advanced medical devices in Latin American countries by the key market players is expected to elevate the market value in the forecast period.

 

The Latin America aortic stent graft market share is also influenced by the growing number of clinical trials to evaluate the effectiveness and safety profile of new aortic stent grafts. Further, the rise in post-market surveillance studies on stent grafts and endovascular aneurysm repair such as the Global Registry for Endovascular Aortic Treatment (the GREAT registry)  is expected to enhance trust among patients and healthcare providers, leading to market expansion in the region.

 

Latin America Aortic Stent Graft Market Segmentation

The report offers a detailed analysis of the market based on the following segments:

 

Market Breakup Categories
Product Abdominal Aortic Stent Grafts, Thoracic Aortic Stent Grafts
End User Hospitals, Ambulatory Surgical Centers, Others
Countries Brazil, Argentina, Mexico, Others

 

Leading Players in the Latin America Aortic Stent Graft Market

The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • Cook Medical, Inc.
  • W.L. Gore & Associates
  • MicroPort Scientific Corporation Inc.
  • Medtronic Plc.
  • Lombard Medical, Inc.
  • Endologix, INC.
  • Terumo Corporation Inc.
  • Cardinal Health Inc.
  • Becton, Dickinson and Company
  • CryoLife Inc.

 

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product   
  • End User 
  • Region
Breakup by Product
  • Abdominal Aortic Stent Grafts
  • Thoracic Aortic stent Grafts 
Breakup by End User 
  • Hospitals 
  • Ambulatory Surgical Centers
  • Others
Breakup by Region
  • Brazil
  • Argentina
  • Mexico
  • Others
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Cook Medical, Inc.
  • W.l. Gore & Associates
  • MicroPort Scientific Corporation Inc.
  • Medtronic Plc.
  • Lombard Medical, Inc.
  • Endologix, INC.
  • Terumo Corporation Inc.
  • Cardinal Health Inc.
  • Becton, Dickinson and Company
  • CryoLife Inc.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology                  
2    Executive Summary
3    Latin America Aortic Stent Graft Market Overview 

    3.1    Latin America Aortic Stent Graft Market Historical Value (2017-2023) 
    3.2    Latin America Aortic Stent Graft Market Forecast Value (2024-2032)
4    Latin America Aortic Stent Graft Market Landscape*
    4.1    Latin America Aortic Stent Graft: Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Latin America Aortic Stent Graft: Product Landscape
        4.2.1    Analysis by Product    
        4.2.2    Analysis by Type
        4.2.3    Analysis by Application
5    Latin America Aortic Stent Graft Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
        5.2.1    Strengths
        5.2.2    Weaknesses
        5.2.3    Opportunities
        5.2.4    Threats
    5.3    Porter’s Five Forces Analysis
        5.3.1    Bargaining Power of Suppliers
        5.3.2    Bargaining Power of Buyers
        5.3.3    Threat of New Entrants
        5.3.4    Threat of Substitutes
        5.3.5    Degree of Rivalry
    5.4    Key Demand Indicators 
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends  
    5.7    Value Chain Analysis
6    Latin America Aortic Stent Graft Market Segmentation (2017-2032)
    6.1    Latin America Aortic Stent Graft Market (2017-2032) by Product    
        6.1.1    Market Overview
        6.1.2    Abdominal Aortic Stent Grafts
        6.1.3    Thoracic Aortic Stent Grafts 
    6.2    Latin America Aortic Stent Graft Market (2017-2032) by End User 
        6.2.1    Market Overview
        6.2.2    Hospitals 
        6.2.3    Ambulatory Surgical Centers
        6.2.4    Others
    6.3    Latin America Aortic Stent Graft Market (2017-2032) by Countries
        6.3.1    Market Overview
        6.3.2    Brazil
        6.3.3    Argentina
        6.3.4    Mexico
        6.3.5    Others 
7     Brazil Aortic Stent Graft Market (2017-2032)
    7.1     Brazil of Aortic Stent Graft Market (2017-2032) by Product    
        7.1.1    Market Overview
        7.1.2    Abdominal Aortic Stent Grafts
        7.1.3    Thoracic Aortic Stent Grafts 
    7.2     Brazil of Aortic Stent Graft Market (2017-2032) by End User 
        7.2.1    Market Overview
        7.2.2    Hospitals 
        7.2.3    Ambulatory Surgical Centers
        7.2.4    Others
8     Argentina Aortic Stent Graft Market (2017-2032)
    8.1     Argentina Aortic Stent Graft Market (2017-2032) by Product    
        8.1.1    Market Overview
        8.1.2    Abdominal Aortic Stent Grafts
        8.1.3    Thoracic Aortic Stent Grafts 
    8.2     Argentina Aortic Stent Graft Market (2017-2032) by End User 
        8.2.1    Market Overview
        8.2.2    Hospitals 
        8.2.3    Ambulatory Surgical Centers
        8.2.4    Others
9    Mexico Aortic Stent Graft Market (2017-2032)
    9.1    Mexico Aortic Stent Graft Market (2017-2032) by Product    
        9.1.1    Market Overview
        9.1.2    Abdominal Aortic Stent Grafts
        9.1.3    Thoracic Aortic Stent Grafts 
    9.2    Mexico Aortic Stent Graft Market (2017-2032) by End User 
        9.2.1    Market Overview
        9.2.2    Hospitals 
        9.2.3    Ambulatory Surgical Centers
        9.2.4    Others
10    Regulatory Framework
11    Patent Analysis

    11.1     Analysis by Type of Patent
    11.2     Analysis by Publication year
    11.3     Analysis by Issuing Authority
    11.4     Analysis by Patent Age
    11.5     Analysis by CPC Analysis
    11.6     Analysis by Patent Valuation 
    11.7     Analysis by Key Players
12    Funding and Investment Analysis
    12.1     Analysis by Funding Instances
    12.2     Analysis by Type of Funding
    12.3     Analysis by Funding Amount
    12.4     Analysis by Leading Players
    12.5     Analysis by Leading Investors
    12.6     Analysis by Geography
13    Partnership and Collaborations Analysis
    13.1     Analysis by Partnership Instances
    13.2     Analysis by Type of Partnership
    13.3     Analysis by Leading Players
    13.4     Analysis by Geography
14    Supplier Landscape
    14.1    Market Share by Top 5 Companies
    14.2    Cook Medical, Inc.
        14.2.1    Financial Analysis
        14.2.2    Product Portfolio
        14.2.3    Demographic Reach and Achievements
        14.2.4    Mergers and Acquisitions
        14.2.5    Certifications 
    14.3    W.l. Gore & Associates
        14.3.1    Financial Analysis
        14.3.2    Product Portfolio
        14.3.3    Demographic Reach and Achievements
        14.3.4    Mergers and Acquisitions
        14.3.5    Certifications
    14.4    MicroPort Scientific Corporation Inc.
        14.4.1    Financial Analysis
        14.4.2    Product Portfolio
        14.4.3    Demographic Reach and Achievements
        14.4.4    Mergers and Acquisitions
        14.4.5    Certifications
    14.5    Medtronic Plc.
        14.5.1     Financial Analysis
        14.5.2    Product Portfolio
        14.5.3    Demographic Reach and Achievements
        14.5.4    Mergers and Acquisitions
        14.5.5    Certifications
    14.6    Lombard Medical, Inc.
        14.6.1    Financial Analysis
        14.6.2    Product Portfolio
        14.6.3    Demographic Reach and Achievements
        14.6.4    Mergers and Acquisitions
        14.6.5    Certifications
    14.7    Endologix, INC.
        14.7.1    Financial Analysis
        14.7.2    Product Portfolio
        14.7.3    Demographic Reach and Achievements
        14.7.4    Mergers and Acquisitions
        14.7.5    Certifications
    14.8    Terumo Corporation Inc.
        14.8.1    Financial Analysis
        14.8.2    Product Portfolio
        14.8.3    Demographic Reach and Achievements
        14.8.4    Mergers and Acquisitions
        14.8.5    Certifications
    14.9    Cardinal Health Inc.
        14.9.1    Financial Analysis
        14.9.2    Product Portfolio
        14.9.3    Demographic Reach and Achievements
        14.9.4    Mergers and Acquisitions
        14.9.5    Certifications
    14.10    Becton, Dickinson and Company 
        14.10.1    Financial Analysis
        14.10.2    Product Portfolio
        14.10.3    Demographic Reach and Achievements
        14.10.4    Mergers and Acquisitions
        14.10.5    Certifications
    14.11    Cryolife Inc.
        14.11.1    Financial Analysis
        14.11.2    Product Portfolio
        14.11.3    Demographic Reach and Achievements
        14.11.4    Mergers and Acquisitions
        14.11.5    Certifications 
15    Latin America Aortic Stent Graft – Distribution Model (Additional Insight)
    15.1     Overview 
    15.2     Potential Distributors 
    15.3     Key Parameters for Distribution Partner Assessment 
16    Key Opinion Leaders (KOL) Insights (Additional Insight)
17    Company Competitiveness Analysis (Additional Insight)

    17.1     Very Small Companies
    17.2     Small Companies
    17.3     Mid-Sized Companies
    17.4     Large Companies
    17.5     Very Large Companies
18    Payment Methods (Additional Insight)
    18.1     Government Funded
    18.2     Private Insurance
    18.3     Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

 

* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.

Key Questions Answered in the Report

The Latin America aortic stent graft market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 5.8% during the forecast period of 2024-2032 and is likely to reach a market value of USD 5.2 billion by 2032. 

The growing demand for minimally invasive surgical techniques to treat vascular diseases is fuelling the demand for the market.

One of the significant trends in the market is the rising technological advancements that are leading to the development of more effective and minimally invasive stent grafts. In January 2024, W. L. Gore & Associates, Inc., announced the FDA approval of it lower profile GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis, aimed at treating complex vascular diseases.

Based on the product, the market is segmented into abdominal aortic stent grafts and thoracic aortic stent grafts.

End users of the market are hospitals and ambulatory surgical centers, among others.

The market segmentation by countries includes Brazil, Argentina, and Mexico, among others. 

The key players in the market are Cook Medical, Inc., W.L. Gore & Associates, MicroPort Scientific Corporation Inc., Medtronic Plc., Lombard Medical, Inc., Endologix, INC., Terumo Corporation Inc., Cardinal Health Inc., Becton, Dickinson and Company, and CryoLife Inc.

Purchase Full Report

Mini Report

$ 2639     $2399
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 4399     $3999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 5829     $5299
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 6929     $6299
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER